Evaluation of G1T38 and SERD XR5-28 in hormone refractory breast cancer
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
G1 Therapeutics Inc.
Start Date
October 1, 2016
End Date
November 30, 2017
Administered By
Pharmacology & Cancer Biology
Awarded By
G1 Therapeutics Inc.
Start Date
October 1, 2016
End Date
November 30, 2017